“Elimination of Hepatitis by 2030”: Present Realities and Future Projections-Reference-Cited by-同舟云学术

“Elimination of Hepatitis by 2030”: Present Realities and Future Projections

Published:2021-11-17 Issue:1 Volume:2 Page:3-8
ISSN:2693-8839
Container-title:Infectious Diseases & Immunity
language:en
Short-container-title:

Author:

Akbar Sheikh Mohammad Fazle,AL-Mahtab Mamun,Khan Sakirul,Yoshida Osamu,Hiasa Yoichi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference52 articles.

1. Implications of birth-dose vaccination against Hepatitis B virus in southeast Asia;Akbar;Vaccines,2021

2. Advances in hepatitis B therapeutics;Soriano;Ther Adv Infect Dis,2020

3. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial;Bourlière;Lancet Gastroenterol Hepatol,2017

4. Biological basis for functional cure of chronic hepatitis B;Martinez;J Viral Hepat,2019

5. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: considerations for future novel therapeutics;Gill;J Viral Hepat,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Does Chronic Hepatitis B Infection Impact on Severity of COVID-19 Infection?;International Journal of Infection;2024-09-01

2. Manipulating the 4-1BB Pathway to Cure HBV;Infectious Diseases & Immunity;2024-08-02

3. Knowledge Gaps and Determination of Attitude and Practice among Medical Students toward Hepatitis B Infection: A Nationwide Cross-Sectional Study;International Journal of Hepatology;2024-03-21

4. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030;Vaccines;2024-03-09

5. Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure;Journal of Clinical and Translational Hepatology;2022-07-01